Head, Market Access & Government Affairs, SINMAL (Singapore, SG, 38986)

Singapore, Singapore Type not listed
Notify me about similar jobs

Astellas Pharma is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

.

We're seeking passionate individuals who thrive in dynamic environments, embrace new ideas and aren't afraid to take intelligent risks. People who act with unwavering integrity and are deeply committed to making a tangible impact.

Working Environment and Location

This position is based in Malaysia and will require on-site work.

(OR) At Astellas we recognize the importance of work/life balance, and we are proud to offer a hybrid working solution allowing time to connect with colleagues at the office with the flexibility to also work from home. We believe this will optimize the most productive work environment for all employees to succeed and deliver. Hybrid work from certain locations may be permitted in accordance with Astellas’ Responsible Flexibility Guidelines.

Working Hours

Purpose and Scope

The role leads market access, pricing, tender and government affairs strategy and execution for Astellas across Singapore and Malaysia, translating regional strategies to local realities to secure and sustain patient access for in-line and pipeline products. It represents payer and ecosystem perspectives internally, engages external stakeholders (payers, authorities, KEEs) and initiates policy-shaping efforts with cross-functional support.

Role and Responsibilities

Healthcare System Knowledge

Possesses expert understanding of how political, economic, social, and legal contexts shape health-system design and operation.

Deep proficiency in pricing, reimbursement, funding, and procurement mechanisms (processes, evidentiary standards, regulatory/legal principles).

Understands decision rights, governance flows, and trends in healthcare financing and policy.

Understands how health system(s) incentivize and dis-incentivize payer and stakeholder behavior and decision making.

Positions local systems within global/regional/national archetypes (payer types, funding sources, HTA approaches).

Anticipates shifts in stakeholder power and articulates implications for access (e.g., rising influence of non-prescribing stakeholders; budget shifts to HCPs).

Identifies opportunities to shape the environment to improve pricing, reimbursement, and access, delivering system improvements enabled by Astellas’ value offerings.

Market Access Strategy

Develops end-to-end pricing and access strategies across the product lifecycle (tenders, reimbursement, stakeholder engagement, access expansion).

Crafts and deploys payer-tailored materials that anticipate objections and present solution pathways.

Designs value-creation strategies beyond clinical evidence (e.g., integrated care, patient support programs) to secure, optimize, and sustain access and uptake.

Delivers successful subsidy/listing outcomes (e.g., MAF, CDL, MOHMF) for relevant products.

Data & Analytics

Understands how evidence is generated, appraised, and applied by payers and stakeholders (providers, patients, health systems).

Translates data into payer-relevant insights that inform funding, procurement, and policy; establishes dashboards to monitor listing and tender KPIs where appropriate.

Integrates full P&L considerations into pricing proposals (list/net price, COGS, rebates/RSAs, tender terms, IRP exposure, volume/mix, OPEX and OP), supported by scenario and sensitivity analyses to ensure optimal margin and sustainability.

Strategic Pricing & Contract Strategy

Designs and implements innovative pricing models for in-line and pipeline assets to maximize timely, equitable patient access.

Understands compliance considerations and risks of pricing practices (competitive law, antibribery regulations) and flags pricing practices which conflict with compliance requirements (competitive law, anti- bribery regulations).

Manages cross-border dynamics (IRP exposure, parallel trade, cross-indication referencing) to optimize country strategies within corporate constraints.

Develops managed-entry and risk-sharing arrangements (price-volume, expenditure caps, performance-linked schemes) with clear risk mitigation and performance management.

Oversees pricing and tender management with cross-functional partners; defines post-award performance metrics and reconciliation processes.

Continue:Role and Responsibilities

External Stakeholder Management

Leads comprehensive mapping, engagement, and communications planning for payers and government authorities.

Directs KEE strategies to build credible advocacy around unmet need, value, and appropriate use.

Leads and owns Patient Access Program (PAP) planning and design end-to-end; establishes governance with Medical and Compliance; defines eligibility, documentation, distribution/dispensing controls, KPIs, and monitoring/audit plans.

HEOR & Evidence Generation / Submission

Leads the affiliate HEOR strategy and roadmap (burden of illness, treatment patterns, RWE, PROs) with endpoints tied to payer decisions, listings, renewals, and indication expansions.

Leads and owns the end-to-end HTA pathway including dossier development and localization /submission, HTA agency timeline control, and coordinated internal and external stakeholder engagement.

Value negotiation strategy: Integrates full financials (list/net, P&L drivers, IRP exposure, rebate/RSA constructs, tender terms) with a clear value narrative (clinical benefit, HEOR/RWE, budget impact, implementation feasibility) to tailor proposals to HTA criteria and decision frameworks, set KPIs/renewal terms, ensure competition-law compliance, and align positions for HTA agencies, payers and healthcare professionals.

Ensures robust and consistent methods for SLRs, NMAs, BIAs and CEAs, in line with local HTA standard

Leverages RWE partnerships (registries, universities, payer data) to inform and integrate with HEOR and evidence generation.

Translates technical outputs into payer-ready evidence (concise narratives, policy briefs, objection-handling materials).

Government Affairs & Policy

Long-term partnerships: Builds enduring, trust-based relationships with MOH divisions, HTA agencies, regulators, healthcare professionals, clinical societies, patient groups, NGOs and industry associations to advance sustainable access.

Policy agenda & engagement model: Sets a proactive GA roadmap aligned to portfolio priorities; maintains stakeholder maps and engagement plans with defined cadences (executive sponsorships, policy roundtables, annual strategy summits).

Sets a proactive government affairs roadmap aligned to portfolio and access priorities (e.g., subsidy frameworks, procurement modernization, pooled-tender policy).

Systematically engages MOH divisions, HTA agencies, and healthcare professionals to inform and shape policy and funding decisions.

Coordinates evidence-based responses to public consultations; convenes roundtables, white papers, and MoUs with clinical societies/NGOs to address system gaps

Anticipates policy risks and manages issues/crises in alignment with anti-bribery and anti-corruption, competition law, and industry codes, in close partnership with Legal and Compliance.

Essential Qualifications

Bachelor’ Degree in any discipline.

Minimum 10 years in ethical pharmaceutical industry and minimum 5 years’ experience in market access & pricing & government affairs.

HEOR/HTA Expertise

Government Affairs experience (policy consultations, MOH/HTA engagement, long-term stakeholder partnerships)

Strategic Thinking & Planning & Agility.

P&L integration into pricing proposals; strong scenario/sensitivity analysis.

Robust product pricing & tender management experience

Proven leadership ability, leading without authority.

Executive presence, prior experience with engaging senior leaders.

Excellent communication and interpersonal skills.

Cross-Functional Capability - affiliate, regional and global teams.

Fluent in English.

Oncology products experience preferred.

Pre-launch excellence and niche therapeutic area best-in-class launch experience preferred.

Preferred Qualifications

Benefits

Careers | Astellas

Salary Range

Why Astellas

We're seeking passionate individuals who thrive in dynamic environments, embrace new ideas and aren't afraid to take intelligent risks.

People who act with unwavering integrity and are deeply committed to making a tangible impact.

Learn more at Astellas.com

Our Organisational Values and Behaviours

Accountability

Courage

Impact

Innovation

Integrity

One Astellas

Outcome Focus

Sense of Urgency

Skills and Capabilities

Organizational Focus

]]>

Job details

Seniority
Not listed
Function
Market Access
Therapeutic area
Not listed
Location
Singapore, Singapore
Employment type
Not listed

How this role compares

Computed from every other active Market Access role in our database, not just this employer's listings.

We currently track 251 comparable Market Access roles across 55 biopharma companies.

251Comparable roles tracked
239Currently active
55Companies hiring similar roles
34Countries represented

Salary context

67 of 251 peers report a salary range (USD, annualized)

Peers share this role's job function. This posting doesn't list a seniority level, so peers aren't narrowed by seniority either -- the range below may span more levels than usual.

This roleSubject Not listed on this posting
Highest disclosed · Vice President, US Market Access Lead - Specialty Care · Pfizer $300,100/yr – $500,100/yr
Peer group range $130,000 – $400,100 (median $208,845)

Where these roles are based

Top locations among the 251 comparable roles

United States118
China20
India15
Japan12
Germany8
Spain6

+ 28 more countries

Seniority mix

192 of 251 peers have a known seniority level

Manager99
Director49
Associate Director28
Senior Director6
Senior6
Executive/VP3
Associate1

Therapeutic area mix

52 of 251 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Neuroscience26
Oncology9
Immunology6
Dermatology & Aesthetics4
Rare Disease3
Respiratory2
Ophthalmology1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

40%similar
Johnson & Johnson Singapore, Singapore
Same function Same country
40%similar
Johnson & Johnson Singapore, Singapore Director
Same function Same country
25%similar
Novartis Casablanca, Morocco Manager
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

25%similar
Novartis Jordan, Jordan
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

25%similar
Novartis Warsaw, Poland Manager
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

25%similar
Viatris Germany GmbH Bad Homburg, Germany Director
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

40%
Head Of Market Access COE
Johnson & Johnson · Singapore, Singapore · Seniority not listed
Function Therapeutic area Seniority Country
25%
Value & Access and PA Head, Levant
Novartis · Jordan, Jordan · Seniority not listed
Function Therapeutic area Seniority Country
25%
Director, Head of Market Access Spain
Viatris Pharmaceuticals S.L. · Madrid, Spain · Director
Function Therapeutic area Seniority Country
25%
Associate Director, Government Pricing
Regeneron Healthcare Solutions, Inc (USA) · Remote, United States · Associate Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.